Skip to main content
. 2022 Aug 3:keac408. doi: 10.1093/rheumatology/keac408

Table 4.

COVID-19 infection following vaccination in relation to immunomodulatory treatment

Medication COVID-19 infection
Vaccine dose N 0 1 2 3
Adalimumab 39 4 0 0 0
Etanercept 39 8 0 0 0
Infliximab 5 0 0 0 0
Golimumab 1 0 0 0 0
MTX 47 7 0 0 0
HCQ 37 2 1 0 0
MMF 23 0 0 0 0
AZA 8 0 0 0 0
SSZ 5 1 0 0 0
Colchicine 793 108 0 13 1
Canakinumab 31 7 0 0 0
Anakinra 9 1 0 0 0
Tocilizumab 7 0 0 0 0